All posts by Caroline Davidson

Submit Abstract | National Conference HIV, HCV & LGBT Health (Due 12/1/17)

SYNChronicity Conference (SYNC 2018) abstracts are due 11:59 pm EST on Friday, December 1, 2017.

Now is the time to submit your abstract to become part of the SYNC 2018 Conference! Don’t miss the chance to share your best practices and research addressing HIV, HCV, and LGBT health with clinicians, service providers, government officials, community-based organization staff, fiscal managers, consumers, and youth, among others.

SYNC 2018 seeks both Track Abstracts and Poster Abstracts.

Abstract Interest Areas & Format

All abstract submissions must address a specific area/specific areas of interest being covered at this year’s SYNChronicity Conference. These include, but are not limited to:

  • HIV and Aging
  • Leadership Development
  • HIV, HCV or LGBT Advocacy
  • Pre-Exposure Prophylaxis (PrEP)
  • Harm Reduction
  • Stigma
  • Trans Women
  • HCV and the Opioid Epidemic
  • Violence and Trauma

All submissions must provide a clear title; description; concerns that need to be addressed; a description of what participants will learn; and details of your proposed strategies, methods, and models.
Both Track and Poster abstract submissions will be considered for SYNC 2018.

Track Abstracts
At least one workshop session per track will be selected through the abstract submission process. Proposed workshops must engage participants, including clinicians, service providers, government officials, community-based organization staff, fiscal managers, consumers – including youth and aging communities – across HIV, HCV, and LGBT health.

Poster Abstracts
Poster session abstracts are similar to track session abstracts, but focus on well-defined original research and/or new and ongoing best practices, programs, and interventions that “sync” approaches, systems or topics.

Decisions will be made by the SYNC 2018 Planning Committee by mid-December.


For more information, visit or e-mail:

Terrence Calhoun
Conference and Events Manager

Scott Brawley
Director of Development

Sign On! Ask Policymakers to Drop Hep C treatment Medicaid Restrictions

We ask that all policymakers take action against hepatitis C.

The State of Hep C website, which houses the NVHR/CHLPI report and report cards, has a “Take Action” page. On this page, you can sign a petition calling for open access. There is also a social media toolkit with sample posts and infographics for sharing.

We urge you to sign the petition and post on social media. Please also forward to your networks and encourage your colleagues to do the same. These actions will amplify the message that state Medicaids must drop all discriminatory restrictions to hepatitis C treatment.

Medicaid programs should open access so that more people can be cured. Our country also needs to address the hepatitis C epidemic as it has addressed other diseases: We need a coordinated effort to educate Americans, and to connect those at-risk with testing and treatment.

Medical innovation created a cure. Let’s utilize it to cut unnecessary long-term medical costs and save lives.

Sign the petition here.

Media Advisory | Hep C RNA Reflex Testing Health Code Amendment Adopted

The NYC Board of Health Amended the Health Code to Improve Complete Hepatitis C Diagnostic Testing in NYC

In order to improve complete hepatitis C diagnostic testing, care and treatment rates in New York City at the population level, the Board of Health adopted an amendment to the Health Code to require laboratories to automatically perform an hepatitis C RNA confirmatory test when there is an initial positive antibody test for hepatitis C. Complete diagnostic testing for hepatitis C is an important first step to ensuring that people are aware of their status and have the opportunity to be treated and cured. Combining these two steps will ensure that patients with hepatitis C are diagnosed immediately the first time they are tested, rather than having to return to the clinician for follow-up visits and testing. The Board of Health approved the Amendment in September 2017, and the law went into effect on October 20th 2017.

In the newly released Annual Report, “Hepatitis B and C in New York City 2016” , the Health Department reported that among 11, 847 newly reported cases of hepatitis C in 2016, 23% never received hepatitis C RNA confirmatory testing to determine whether they have active, current infection. The Health Department also reports on an analysis of patient outcomes for people reported with active hepatitis C infection in 2015, finding that only a third initiated treatment. And more than half of deaths related to hepatitis C in 2015 occurred prematurely, in people aged 65 or younger.

Hepatitis C related liver disease progression, cancer, premature death and ongoing transmission of the virus can be prevented by ensuring that people with active hepatitis C are appropriately tested and treated to cure the infection. Treatment is now only eight to twelve weeks with all oral well tolerated medications, and almost all people treated can be cured regardless of comorbid conditions, drug use or alcohol consumption.

The Health Department’s policy approach to improving hepatitis C clinical practice is important as 146,500 people are estimated to be infected hepatitis C and only 16% are estimated to be cured. New York City is the first in the nation to mandate hepatitis C antibody to reflex RNA testing by laboratories, an important health policy advancement strategy that may be replicable across the nation.

This letter has been sent to NYC laboratories informing them of the amendment.

Hep B & C in NYC: 2016 Annual Report of Surveillance & Activities

On October 4, 2017, the New York City Health Department released its “Hepatitis B and C: Annual Report of Surveillance and Activities, 2016.”

Executive Summary

Viral hepatitis B and C are blood-borne pathogens that are prevalent in New York City (NYC). Both can lead to severe liver disease, cancer and premature death. An estimated 1.2 percent of all New York City residents (about 100,000 people) have hepatitis B, and 2.4 percent of New York City residents aged 20 and older (about 146,500 people) have hepatitis C.

This report presents an overview of the New York City Health Department’s 2016 surveillance and research data on hepatitis B and C in NYC, as well as the Health Department’s programmatic activities to address these epidemics.

Surveillance Data
  • In 2016, 8,439 people were newly reported with chronic hepatitis B, an increase (9.3 percent) from 2015.
  • In accordance with the 2016 revision of the Council of State and Territorial Epidemiologists (CSTE) and the Centers for Disease Control and Prevention (CDC) case definition for chronic of hepatitis C, laboratories are required to report all positive hepatitis C antibody tests. As a result of this change in definition, 11,847 people were newly reported with chronic hepatitis C in 2016, an increase (67.8 percent) from 2015.
  • In 2016, 3,781 people were newly reported with confirmed hepatitis C (RNA positive) infection, a decrease (9.4 percent) from 2015.
Research and Evaluation

Research and evaluation conducted in 2016 revealed that:

  • Approximately 3,400 Medicaid recipients were prescribed hepatitis C treatments, a 61 percent decrease from 2015.
  • In 2016, ledipasvir/Sofosbuvir accounted for 47 percent of the hepatitis C medications prescribed to Medicaid patients, compared with nearly three-quarters of prescriptions in 2015.
Direct Services, Capacity Building, Education and Policy

In 2016, the Health Department:

  • Enabled 99.5 percent (1,508) of the 1,516 babies born to hepatitis B positive mothers served by the Health
    Department Perinatal Hepatitis B Program to receive hepatitis B post-exposure prophylaxis.
  • Launched a new program to improve linkage to care rates for pregnant women infected with hepatitis B.
  • Managed three patient navigation programs reaching more than 6,000 hepatitis B and C patients.
  • Managed a comprehensive hepatitis C care coordination program enrolling 2,551 patients
  • Developed and administered a City Council-funded Hepatitis C Peer Navigation program at all 15 NYC syringe exchange programs in NYC.
  • Provided primary and secondary prevention, as well as reinfection prevention services, to 4,438 at-risk people.
  • Administered more than 12,000 hepatitis B vaccine doses.
  • Organized pharmacist advocates to discuss the feasibility of allowing hepatitis C and HIV rapid testing by community pharmacists.
  • Closely monitored legislation to increase drug price transparency and lower the cost to insurers and patients.
  • Joined with the New York State Department of Health to advise community advocates beginning a statewide effort to eliminate hepatitis C.
  • Convened 23 Hep Free NYC network meetings with 860 participants representing 135 organizations from all five boroughs.

In the news:

POLITICO Pro New York Health Care: City continues to see hepatitis B increase [visible to POLITICO Pro members here]

Training | Community Health Worker: Core Competencies


Core Competencies | 35-hour curriculum

November 13-17, 2017 | 5 days – 9 AM – 5 PM

Registration Deadline October 27th.


Developed in direct response to the stated needs of both CHWs and their employers and supported by original research conducted in partnership with Columbia University’s Mailman School of Public Health.

Core Skills

Designed to help CHWs develop the core skills they need to conduct the tasks and fulfill the roles that have come to describe the CHW practice.

  • This training is by far the best I have attended in my 10 plus years in the human services field.
  • Gave me knowledge and opened my eyes on how to understand life better. I learned how to be compassionate. It changed my way of thinking.
  • They bring education to a whole new standard and make you want to think more.
  • I feel incredibly empowered.
  • The most interesting training I’ve ever had. It gave me all of the basics of what a CHW has to deal with.
  • I feel more competent in being able to actually make changes from the root of a situation.
  • Teaches how to empower the people they serve.
  • This week has changed me forever. I will remember this as a watershed moment in my life.

Email April Hicks for rates and registration.

Registration Deadline October 27th.

Documentary | Hep B BE ABOUT IT now on YouTube!

In recognition of Liver Cancer Awareness Month, Gilead Sciences is excited to share that you can now watch BE ABOUT IT – the documentary highlighting the impact of chronic hepatitis B (hep B) on the Asian American community – on the Gilead YouTube channel! We are thrilled to be able to make the film available to the public and hope by doing so we will continue to inspire a more open dialogue about hep B.
You can watch the video below ⇓

We invite you to share this information with your community members so that they can watch the full film and spread the word!

Project SUCCEED: Curing Hep C in People with HIV in NYC


Scaling Up Co-Infection Care & Eliminating Ethnic Disparities


More than 4,200 people are living with HIV and current Hepatitis C (HCV) infection in New York City, the majority of whom are people of color. People co-infected with HIV and HCV are at high risk for developing liver disease, liver cancer and premature death.

HCV can now be treated and cured in just a few months with all oral regimens and few side effects. The majority of patients treated can be cured, even people who are actively using drugs or alcohol, or who have a detectable HIV viral load. Being cured of HCV improves the chances of living a longer healthier life. Everyone deserves a cure!

Project SUCCEED (Scaling up Co-Infection Care & Eliminating Ethnic Disparities) is a NYC Health Department initiative that aims to improve HCV screening, linkage to care and treatment rates in people living with HIV. Project SUCCEED will use surveillance data to identify the health care practices in NYC with the greatest number of HIV/HCV co-infected patients and provide training and technical assistance to support improved HCV care. Project SUCCEED Health Care Access Specialists will conduct case finding and linkage to care for patients who are lost to follow-up.

Join us in the effort to eliminate hepatitis C in people living with HIV!

We are offering the following training, technical assistance and resources to HIV providers:

Hepatitis C Clinical Provider Training
Ten CME weekly webinar based training for clinical providers (MD, DO, NP, PA, RN) interested in treating HCV, with an option to participate in a half day clinical preceptorship

Hepatitis C Patient Navigation Training
Full day training on HCV outreach, screening and care navigation for non-clinical providers

Hepatitis C Medication Coverage Training
Two hour training on getting HCV medications covered by health insurance

Technical Assistance
Provision of recommendations and support to improve HCV care at HIV clinical sites

Hep C Toolkit
Online and print resources for patients, clinical and non-clinical providers

Direct to Patient Outreach and Linkage to Care
Health Department Health Care Access Specialists can help find patients and link them to HCV care

HIV/HCV Treatment Access Committee
Committee of the NYC Hep C Task Force that will meet quarterly to ensure all people living with HIV in NYC are screened, treated and cured of HCV

To learn more or participate, contact:

Sign-On! Ask Congress to Oppose Cuts to Domestic HIV/Hep Programs in FY2018

Congress is now beginning the process of crafting a final FY 2018 funding bill. Both the House and Senate have proposed to cut or eliminate several HIV programs, which would also impact hepatitis work within those programs. The House proposed to completely eliminate the Secretary’s Minority AIDS Initiative Fund, cut SAMHSA’s Minority AIDS Initiative programs by $17.7 million, and eliminate the Title X and Teen Pregnancy Prevention Programs. The Senate has proposed to cut the Housing Opportunity for Persons with AIDS Program by $26 million. Both the Senate and House have proposed to increase funds for abstinence-only-until-marriage education.

Now, we must call on Congress to protect these programs and reject the cuts that have been proposed.
The AIDS Budget and Appropriations Coalition (ABAC) has drafted a sign-on letter urging Congress to reject these proposed cuts and restore funding to those programs that were cut last year.

Consider signing your organization on to the attached letter from ABAC urging Congress to reject the proposed budget cuts and adequately fund domestic HIV and related programs in FY 2018.

If your organization would like to sign-on please click here.

The sign-on deadline is COB, Wednesday, October 25th.

If you are on the ABAC auto-sign-on list, your organization’s name is already included on the draft letter and you do not have to respond, but there is an option to remove your name from this letter. There is also an option to add your organization’s name to the auto-sign-on list and to be added to the ABAC listserv.

If you need assistance signing on to the letter, please contact Nick Armstrong at

Please share this letter with your networks.

Thank you very much.

Carl Schmid
The AIDS Institute

Emily McCloskey

Carl Baloney, Jr.
AIDS United

Job | Hepatitis Outreach Network (HONE) Project Coordinator @ Mount Sinai


The Hepatitis Outreach Network (HONE) Project Coordinator manages the hepatitis B and C screening and linkage to care program conducted by the Icahn School of Medicine at Mount Sinai. The program aims to screen at least 300 at-risk individuals annually for hepatitis B and C. The HONE Project Coordinator collaborates with community organizations to conduct community-based viral hepatitis screening and linkage to care. S/he shall assure the program’s progress by building partnerships with communities at risk for viral hepatitis, organizing and scheduling education and screening events, linking positive persons to care at Mount Sinai Hospital and our linkage to care affiliates, data entry and conducting quality assurance and improvement of the project. The HONE Project Coordinator will also be expected to provide direct client services and conduct counseling, phlebotomy, follow-up, and referral services.

Job Description:
Duties and Responsibilities:

  • Provide direct hepatitis B and C pre- and post-test counseling.
  • Collect hepatitis B and C blood samples (i.e., phlebotomy).
  • Order laboratory tests and submit blood samples in a timely manner.
  • Refer hepatitis B and C positive individuals to follow up care accordingly and navigate them to follow up medical care (i.e. schedule appointments, accompany select patients to appointments).
  • Collaborate with HONE and gastroenterology, liver, and infectious disease clinics to ensure client engagement and maintenance in care for hepatitis B and C positive individuals.
  • Manage data entry through the supervision and training of data entry staff and volunteers.
  • Conduct quality assurance and improvement of education, counseling, testing, referrals, follow-ups, reporting, and data collection
  • Write and present abstracts, updates and reports on the findings and status of the program and work with grant writers to secure future funding for the program.
  • Represent and advocate for HONE through annual events, coalition meetings, and/or conferences.
  • Adhere to the Health Insurance Portability and Accountability Act (HIPAA) of 1996 in order to maintain patient confidentiality.
  • Oversee program operations including ordering and inventory of supplies.
  • Communicate effectively and professionally with people, members of the health care team and project leadership
  • Participate in expansion of viral hepatitis screening efforts at additional health partners sites
  • Maintain linkage to care agreements with federally qualified health centers/ community health centers for undocumented and uninsured patients
  • Contribute to scholarship activities including presentations and manuscript development
  • Oversees all research related activities associated with the project including development/maintenance of IRB documents in a timely manner
  • Prepares and ensures grant applications, IRB/GCO documents are submitted.
  • Assists the Principal Investigator in the preparation of new protocol submissions, protocol amendments, and renewals of ongoing research projects related to HONE.
  • Obtains informed consent under supervision of the Principal Investigator, for studies enrolling vulnerable subjects, and for studies involving genetic tests.
  • Evening and/or weekend hours will be required.
  • Bachelor’s degree in sciences or related field is required, Master’s degree preferred
  • Bilingual in one of the following languages is preferred: Spanish, French or Chinese
  • Full Time
  • Experience with Microsoft Excel required and other computer software including EPIC preferred
  • Excellent interpersonal and communication skills, both spoken and written
  • At least two (2) years experience in clinical care, community based work and/or research
  • Phlebotomy certified (or willingness to obtain)
  • Exceptional attention to detail and accuracy
  • Program management experience preferred
  • Fluency in Microsoft Office required

None specified


4-year degree


To Apply: Please email letter of interest and CV to:

Ponni Perumalswami, MD |

9-27-17 Hep B Coalition Meeting Highlights

Read full meeting highlights here.

NYC Hep B Surveillance Update
Angelica Bocour, MPH, Viral Hep Surveillance Director, NYC Health Dept –

Charles B. Wang – Modeling an FQHC-based Hep B Program
Amy Tang, MD, Charles B. Wang Community Health Center –

NYC Hep B Advocacy Update
Amy Tang, MD, Hep B Coalition Advocacy Chair –
Hep Free NYC Committee Updates

Caroline Davidson, MPH, Communications Coordinator, NYC Health Dept –

Coalition against Hepatitis in People of African Origin (CHIPO) NYC
Farma Pene, Healthcare Access Specialist, NYC Health Dept –

Hep B Patients for a Cure Committee
Henry Chang –

Community Health Workers Committee
Rinzin Wangmo, Viral Hep Policy Intern, NYC Health Dept. –
Communications Committee
Shanaz Hosein, Chair of the Hep Free NYC Communications Committee –

Job | Hep C Research Program Coordinator @ Mount Sinai

Research Program Coordinator
REACH Program
Division of General Internal Medicine
Department of Medicine
Icahn School of Medicine at Mount Sinai

We are currently seeking a Research Program Coordinator for the Respectful & Equitable Access to Comprehensive Healthcare (REACH) Program in the Division of General Internal Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai and Mount Sinai Hospital. The REACH Program takes a patient centered, harm reduction approach to healthcare and prevention which encompasses the medical, psychosocial, and socio-structural aspects of hepatitis C virus (HCV) infection, including addressing both overall health of people who use drugs, and societal stigma.

The REACH program has a four-part mission to (1) provide comprehensive HCV prevention and care services to our patients and our community, (2) develop best practices and tools for healthcare providers centered on HCV treatment and prevention services, and to provide trainings to disseminate these best practices, (3) conduct research and contribute to scientific
advancement in the HCV and drug user health field, (4) advocate to inform and advance policy that promotes equitable HCV and general health prevention and care for individuals and at the population level.

What You’ll Do:
The Research Program Coordinator is responsible for the day-to day administrative oversight of the REACH program’s staff as well as research and clinical activities. The Research Program Coordinator manages pre-and post-award submissions and materials, performs fiscal oversight of all assigned projects, presents data and program information to external audiences, prepares final reports from study for sponsors, maintains and builds new relationships with community partners, and contributes to the execution of the strategic plan of the REACH program.

The role and responsibilities of the Research Program Coordinator are described below.

Duties and Responsibilities:

  1. Manages program logistics and deliverables required by the sponsors.
  2. Supervises program staff and data collection methods.
  3. Works with program staff to ensure the highest quality of data.
  4. Orders program supplies and works closely with the Program Director and Research Manager to oversee study spending.
  5. Prepares sponsor and regulatory (Grants and Contracts Office, IRB, Sponsored Projects Accounting) reports for program grants.
  6. Assists with pre-award grant submissions.
  7. Networks with existing community partners and builds relationships with new community partners.
  8. Contributes to academic presentations and publications.

What You’ll Bring:

Master’s degree in Natural Sciences, Public Health, Public Policy, or the Social Sciences

Bachelor’s degree in Natural Sciences plus 5 years of progressive research experience with some experience in research administration preferred

General Skills:

  • Excellent written and oral communication skills
  • Exceptional attention to detail and accuracy
  • Experience with study management and grant submissions
  • Experience with personnel management
  • Experience in the field of harm reduction, substance use treatment, or viral hepatitis

Minimum three years experience (5 years if no Master’s degree) in data management and study coordination in healthcare or basic research.

Who We Are:

Over 35,000 employees strong, the mission of the Mount Sinai Health System is to provide compassionate patient care with seamless coordination and to advance medicine through unrivaled education, research, and outreach in the many diverse communities we serve.

Formed in September 2013, The Mount Sinai Health System combines the excellence of the Icahn School of Medicine at Mount Sinai with seven premier hospital campuses, including Mount Sinai Beth Israel, Mount Sinai Beth Israel Brooklyn, The Mount Sinai Hospital, Mount Sinai Queens, Mount Sinai Roosevelt, Mount Sinai St. Luke’s, and New York Eye and Ear Infirmary of Mount Sinai.

The Mount Sinai Health System is committed to the tenets of diversity and workforce that are strengthened by the inclusion of and respect for our differences. We offer our employees a highly
competitive compensation and benefits package, a 403(b) retirement plan, and much more.

The Mount Sinai Health System is an equal opportunity employer. We promote recognition and respect for individual and cultural differences, and we work to make our employees feel valued
and appreciated, whatever their race, gender, background, or sexual orientation.
EOE Minorities/Women/Disabled/Veterans

To Apply: Submit cover letter and resume to:
Jeffrey Weiss, PhD, Director, REACH Program

Comment | NYC Health Code Amendment – Reporting Negative Hep B Test Results (Due 10/25/17)

The NYC Health Department is proposing that the Board amend Health Code §13.03(b)(3)(A) to require laboratories to report all hepatitis B virus (Hep B) DNA test results, including negative results. The Health Department currently requires laboratories to report only positive Hep B DNA results, in addition to other positive Hep B test results.

View a summary of the amendment as a PDF

Hep B DNA testing is performed on individuals who have tested positive for Hep B. Hep B DNA tests measure viral load and whether the patient has chronic (active) Hep B, requiring treatment. For patients already diagnosed with chronic Hep B, DNA test results provide important information regarding infectiousness, treatment eligibility, and risk for development of liver cancer. For patients being treated for Hep B, DNA test results provide information regarding treatment outcome (i.e., the extent to which the patient cleared the infection).

The number of Hep B cases is rising nationally and in New York City. More than 100,000 New Yorkers are estimated to be living with chronic Hep B, with 8,439 new cases diagnosed in 2016, an increase of 18.8% since 2013. The majority of individuals infected with Hep B as adults will clear the virus on their own, but many New Yorkers will develop chronic Hep B. Chronic Hep B can lead to serious health issues, including cirrhosis and liver cancer.

The  proposed amendment will allow the Health Department to estimate the proportion of New Yorkers infected with Hep B who are appropriately tested and linked to care; identify gaps in access to care; develop targeted interventions to increase linkage to care and improve provider knowledge of Hep B testing and treatment guidelines; and increase monitoring to reduce Hep B-related morbidity and mortality.

This proposed amendment is now open for public comment! 

All comments must be made by 5 PM on October 25th. You can comment online, by email, mail, fax, or in-person at the public hearing.

A public hearing will be held October 25th from 10 AM – 12 PM at:
NYC Department of Health and Mental Hygiene
Gotham Center, 42-09 28th St., Room 14-43
Long Island City, NY 11101-4132

To comment online, you must log in or register. You can then write and submit your comment from the amendment page.

To comment by mail, mail to:
NYC Department of Health and Mental Hygiene
Gotham Center, 42-09 28th St., CN 31
Long Island City, NY 11101-4132

To comment by fax, fax to:
NYC DOHMH, 347-396-6087

Funding | Supporting Syringe Service Programs (Due 11/10)

View announcement here.

AIDS United, in partnership with Elton John AIDS Foundation, Levi Strauss Foundation, Open Society Foundations, and H. Van Ameringen Fund, is pleased to announce the opportunity for grant support through the Syringe Access Fund. Through the Round Ten Grant Cycle, the Syringe Access Fund will award approximately $2 million in new grants, covering a two-year period by the start of 2018.

Since the HIV epidemic began, injection drug use has directly and indirectly accounted for approximately one-third of all AIDS cases in the United States and is responsible for most of the new cases of hepatitis C. Currently, 91 people in the United States die every day from an opioid overdose. Widespread increases in opioid use and lack of access to evidence-based treatment and public health services has contributed to injection-related HIV and hepatitis C outbreaks.

Since the early 1980s, Syringe Services Programs (SSPs) have been an important public health intervention to stop the spread of blood borne diseases. SSPs represent one of the most successful evidence-based approaches for reducing the spread of HIV and hepatitis C. They also provide a doorway for highly marginalized people to enter larger systems of health, drug treatment, and social services that may otherwise feel overwhelming and discriminatory toward people who use drugs.

The primary goal of the Syringe Access Fund is to provide core support for programs that demonstrate:

  • An ability to provide high quality syringe access services to one or more identified population(s); and
  • An ability to conduct local, statewide, or national-level policy advocacy initiatives that demonstrate concrete objectives and activities to expand access to sterile syringes.

Through the Syringe Access Fund, AIDS United will provide grants to support work in the following areas:

  • Syringe Access Direct Services: Access to sterile syringes through syringe services programs; and
  • Education/Mobilization: Policy/advocacy campaigns focused on improving public policy at local, state, and/or national levels.

Applicants are eligible to apply for funding up to $75,000 and must be able to utilize funds over a 2-year period beginning February 1, 2018, and ending January 31, 2020.

AIDS United is providing three methods of submission for this initiative – written application, phone/video conference call, or video submission:

  • Written applications are due no later than 5 pm Eastern Time on November 10, 2017.
  • Phone/video conference call application – appointments must be made no later than 5 pm Eastern Time on October 13, 2017.
  • Video submissions are due no later than 5 pm Eastern Time on November 10, 2017.

Late applications will NOT be considered. 
All applications must be submitted electronically via AIDS United’s online application system or via a telephone/video conference. Download the Request for Proposals in English here and Spanish here.

Job | Director of Syringe Distribution, Outreach and Advocacy @ NYHRE

Job Summary

NYHRE is looking for a Director of Syringe Distribution, Outreach and Advocacy to work closely with the organization’s leadership team to manage the syringe distribution program and associated outreach services. This includes both overseeing the related peer training program and street-based harm reduction services,
such as overdose prevention and intervention trainings. This position also supports the organization’s advocacy and policy initiatives.

As a member of the Senior Management Team (SMT) this position is vital to ensuring that NYHRE consistently demonstrates a commitment to improving the lives of people who use drugs and that the agency culture grows and develops in a way that prioritizes services that provide dignity and respect to human beings who have been subjected to trauma, criminalization, stigma and shame in many other settings.


Key Responsibilities

  • Manage, develop, and expand NYHRE’s syringe distribution program, including its outreach activities, UPRISE Peer Training Program, and advocacy efforts
  • Provide guidance, supervision, and ongoing training for program participants and staff
  • Develop, implement, and maintain program policies and procedures that meet the needs of program participants, support the agency’s philosophy, and are in accordance with applicable Federal, State, and local government funding agreements
  • Manage inventory of all outreach supplies, including injection equipment and safe sex supplies
  • Seek and develop funding opportunities to purchase additional items as needed, as well as enhance services for participants, including potential grants and alternative fundraising efforts
  • Develop a strategy to create a system for Peer Educators to be certified by the NYS Peer Worker Certification Process
  • Coordinate agency outreach activities, including working directly with Washington Heights CORNER Project on a strategic affiliation to expand service delivery in a cooperative manner
  • Coordinate site management to ensure the efficient allocation of resources and staff across sites
  • Manage contract deliverables and monthly reporting requirements
  • Coordinate with the Data and Evaluation team to accurately capture and document outcomes.
  • Continuously monitor and report on outcomes, service deliverables and participant satisfaction
  • Maintain awareness of legislative, budgetary, and regulatory issues at the local, national, and global level that affect people who use drugs, sex workers, and people living with HIV/AIDS
  • Identify and participate in events that will increase NYHRE’s activism profile and connection to the
  • Educate participants about the role of activism in social justice gains and motivate them to get involved in advocating for themselves and demanding rights for themselves and their communities
  • Produce written reports and presentations as required and on -time
  • Represent NYHRE as necessary in the community (i.e., community planning bodies, community boards, police precincts), at conferences, and with other service providers.
  • Develop and maintain strategic relationships with local, regional, state, and federal representatives, as well as allied organizations, community organizing groups, coalitions, and other community
  • Participate in regular management meetings
  • Monthly report to the Executive Director
  • Other duties as assigned


Requirements and Experience

  • Should have 5-10 years direct service experience with marginalized populations including active drug  users, sex workers, and formerly incarcerated individuals. Experience with the delivery of street-based services and outreach strongly preferred.
  • Minimum 5 years experience with program management, contract management and supervision. Must have experience managing multiple contracts with overlapping service categories.
  • Significant work or life experience in the areas of substance use, sex work, and HIV and HCV desired. Knowledge of the Bronx and East Harlem IDU/ substance use communities preferred.
  • Must be dedicated to advancing an agenda of equal rights and social justice for marginalized individuals, especially through participation in advocacy, and community activism.
  • Must have strong interpersonal and team building skills, excellent communication and presentation skills, and the ability and willingness to be hands-on and creatively solve problems as they arise.
  • High Proficiency with MS Office (including Word, Excel and Outlook), relational databases, and use of the Internet required.
  • Must be willing and able to work outdoors at our street sites, hours may vary.
  • Must have a valid driver’s license, a clean driving record and be able to drive a Sprinter van (commercial license not necessary).
  • Bilingual (Spanish) preferred


Send your resume, a cover letter that effectively addresses the above-mentioned responsibilities and requirements as well as demonstrates your ability to contribute positively to the agency, and salary requirements to Zip Recruiter, or idealist.


NYHRE is an Equal Opportunity Employer. Individuals who have personal experience with drug use, PLWHA, women, people of color, members of the LGBTQ community, and the formerly incarcerated are strongly encouraged to apply – Residents of the Bronx and Harlem encouraged to apply.

View job posting here | For other details please feel free to contact Liz Evans: 212.235.2004

Job | Viral Hepatitis Testing and Linkage to Care Coordinator @ African Services Committee (Part-Time)

View job post here 
Please send resume plus cover letter to

JOB TITLE: Viral Hepatitis Testing and Linkage to Care Coordinator (Part -Time)

JOB SUMMARY: The Viral Hepatitis Testing and Linkage to Care Coordinator (“Hepatitis Program Coordinator”) manages the hepatitis B and C screening and linkage to care program conducted jointly by African Services Committee (ASC) and the Hepatitis Outreach Network (HONE) at the Icahn School of Medicine at Mount Sinai. The program aims to screen 500 high-risk individuals annually for hepatitis B and C. The Hepatitis Program Coordinator collaborates with ASC’s Testing Center Coordinator and with the Hepatitis Program Patient Navigator in conducting on-site and off-site viral hepatitis screening and linkage to care. S/he shall assure the program’s progress by holding Testing Center staff trainings, attending Testing Center team meetings, and conducting quality assurance and improvement of outreach, education, counseling, testing, follow-up, and referral services. The Hepatitis Program Coordinator will also be expected to provide direct client services and conduct counseling, hepatitis education, phlebotomy vaccination, follow up and referral. S/he is responsible for ensuring referral of hepatitis B and C positive clients to follow-up care within 90 days to gastroenterology, infectious disease, and liver clinics as appropriate. The Hepatitis Program Coordinator organizes and participates in testing events in the community; conducting, on average, two (2) events per month.


The Viral Hepatitis Testing and Linkage to Care Coordinator shall:

  • Outreach to high risk immigrant community organizations, and coordinate off site testing events
  • Provide direct hepatitis B and C pre- and post-test counseling.
  • Collect hepatitis B and C blood samples (i.e., phlebotomy).
  • Order laboratory tests and submit blood samples in a timely manner.
  • Refer individuals who lack serological evidence of hepatitis B immunity to ASC staff authorized to vaccinate or to offsite vaccine programs.
  • Refer hepatitis B and C positive individuals to care accordingly.
  • Collaborate with Testing Center staff before, during, and after hepatitis B and C screening to maintain open communication and a high standard of care.
  • Collaborate with HONE and gastroenterology, liver, and infectious disease clinics to ensure client engagement and maintenance in care for hepatitis B and C positive individuals.
  • Manage data entry through the supervision and training of data entry staff and interns..
  • Conduct quality assurance and improvement of education, counseling, testing, referrals, follow-ups, reporting, and data collection through chart reviews, case conferences, and direct observation of staff.
  • Write and present abstracts, updates and reports on the findings and status of the program and work with grant writers to secure future funding for the program.
  • Represent and advocate for ASC’s Hepatitis Program through annual events, viral hepatitis coalition meetings, and/or conferences.
  • Collaborate with ASC’s Communications Department regarding advertising campaigns and public relations for the Viral Hepatitis Program.
  • Report to the New York City Department of Health and Mental Hygiene, to HONE, and to any other funders.
  • Adhere to the Health Insurance Portability and Accountability Act (HIPAA) of 1996 in order to maintain patient confidentiality.
  • Oversee overall program operations including ordering and inventory of supplies.
  • *Occasional evening and/or weekend hours may be required.



  • Minimum education requirement: Bachelor’s degree in health, social sciences or natural sciences
  • Preferable: MPH, MS, BSN, and/or other clinical or public health degree
  • At least two (2) years experience in clinical care and/or research
  • Phlebotomy (can train after hire)
  • Familiarity with basic program evaluation methodology a plus
  • Program management experience preferred
  • Fluency in Microsoft Office required
  • Work experience in Africa or with African immigrant populations a plus
  • Bilingual English/French required
  • Solid interpersonal and communication skills, both spoken and written


Salary is $22,500 with benefits; position serves 20 hours per week.

Please send resume plus cover letter to

Job | Bilingual Hep C Patient Navigator @ BOOM!Health

The Patient Navigator (PN) The PN assesses HCV positive individuals and provides linkage the HCV medical care in order to get them into treatment.  Once in HCV treatment the PN provides ongoing support in order for clients to remain in HCV care throughout the course of their medical treatment. Once treatment has been completed the PN will conduct a 3 month follow up to ensure that HCV has been successfully cured.  In addition to providing linkage to HCV medical care, the PN will make referrals on the client’s behalf to obtain full range of services needed.  The PN will utilize a Harm Reduction Model of Care in order to address barriers such as substance abuse and medical non compliancy issues in effort to better assist clients towards meeting their goals.


  1. Conduct intakes, assessments and referrals on an as needed basis, for clients and collaterals.
  2. Assist in identifying, arranging and coordinating all HCV medical and follow up services.
  3. Completion of all chart documentation, recording of statistics, returning telephone calls to client and other agencies providing services to client and/or collaterals.
  4. Ensure clients are linked to medical care, adhere to their treatment regimen and remain in care.
  5. Conduct home visits as needed to monitor services and client status.
  6. Assist in monitoring the progress of clients.
  7. Assist the client in complying with scheduled appointments; accompany and escort clients to and from appointments when necessary.
  8. Complete all documentation in a timely manner, including weekly schedules and weekly progress notes.
  9. Conduct case conference with other providers in order to discuss client barriers and progress.
  10. Attend training & seminars.
  11. Attends monthly NYCDOH Check Hep C meetings at Queens Borough Hall.
  12. Other duties as assigned.


BA degree in public health, human services or related area with one year of qualifying experience or an Associates Degree with 2 years relevant experience.   Knowledge of hepatitis C virus, means of transmission, substance use and SMI.  Knowledge of community resources, public benefits and sensitivity towards individuals infected with HCV.  Excellent interpersonal and communication skills. Bilingual (Spanish speaking) preferred.

If interested, send updated resume to Charles Bold, Vice President of Harm Reduction and Wellness at

Join the new Hep Free NYC Community Health Workers Committee!


Hep Free NYC Community Health Workers Committee

We are pleased to announce the establishment of Hep Free NYC Community Health Workers (CHWs) Committee. Continuing the strong foundational work done by all the CHWs advocates in New York City and beyond, the work of this subcommittee will focus on organizing community efforts to standardize roles across disciplines and secure stable funding for patient navigation through the CHW model, as seen in other states.

Community Health Workers have been an integral part of the healthcare system, not only in states where they are certified and can be paid by insurance but also in New York. Their work is well-documented for increasing access to healthcare,  improving the quality of health care, reducing health disparities, and reducing health care costs. To this end, our purpose is to work toward ways to make the roles of CHWs sustainable and rewarding for both CHWs and the communities they serve.

The first Hep Free NYC Community Health Workers Committee will be held on Thursday, September 21, 2017 from 3.30 pm to 5 pm. Please RSVP.

Directions to NYC Department of Health and Mental Hygiene

42-09 28th Street
Room # 14-43
Long Island City, NY  11101-4132

By subway:

  • Take the N, Q or 7 train to Queensboro Plaza.  Exit through the turnstyles to the south side of Queens Plaza (You will walk on an overpass over the street).  Walk east for 2 blocks.  You will cross 27th Turn right on 28th Street.  NYC DOHMH is the tall glass building on your left.
  • Take the E, M, or R train to Queens Plaza.  Walk west one block on Queens Plaza.  Turn left on 28th DOHMH is the tall glass building on your left.
  • Take the G train to Long Island City/Court Sq.  Walk northeast on Jackson Avenue for 6 blocks.  Turn left on 42nd Road and walk one block.  Turn right on 28th DOHMH is the tall glass building on your right.

When you enter the building, you will have to check in with security.  Please have photo ID ready.

Please contact us for any inquiry:

Job | C-Change Project Coordinator @ Philadelphia Dept. of Public Health – HepCAP

Organization: Philadelphia Department of Public Health – HepCAP

Posting Date:09/01/2017

C-Change Project Coordinator

This position involves high level oversight, staff supervision, and project management for the C-Change program.  The Project Coordinator will oversee and coordinate the efforts of the C-Change patient navigators, and will serve as a connection between Hepatitis C Allies of Philadelphia (HepCAP), the Philadelphia Department of Public Health (PDPH), the Health Federation of Philadelphia, the C-Change sites (Centers of Excellence [COE] for medication assisted treatment and Prevention Point Philadelphia) and the C-Change staff, including the Principal Investigator (PI) and the Co-Principal Investigators (Co-PIs), and the funders.  The coordinator will develop and manage Memorandums of Understanding (MOUs) between the COEs and the Health Federation.  They will also ensure that MOU deliverables are met. They will oversee the linkage coordination component of this project by supervising the navigators and ensuring that each C-Change site has a process in place to work with their assigned navigator(s). The coordinator will also be responsible for creating the database for and maintaining the data collected from the research component of the study.  The person filling this position will work very closely with Health Federation staff, HepCAP, the PI and Co-PIs, and PDPH staff to ensure project objectives are met.

How to Apply:

 Send resume and cover letter, including desired salary range, to no later than Sept. 18, 2017.

Download Full Job Description

Call for Abstracts | Conference on Retroviruses and Opportunistic Infections (Due 9/27/17)

Abstract submissions for the 25th Conference on Retroviruses and Opportunistic Infections (CROI) are now being accepted. The deadline for general abstract and scholarship submissions is September 27, 2017. Late-breaker abstract submissions are due by January 16, 2018. CROI 2018 will be held March 4 through 7, 2018, in Boston, Massachusetts.

To submit an abstract, visit the CROI website.

New in 2018

  • Abstracts may list up to 15 authors (or 14 authors and the name of a research group)
  • All authors on accepted abstracts will have access to early registration beginning November 15, 2017
  • Research collaborators and all other authors will have access to early registration beginning November 22, 2017

Abstracts should present new research or developing information on HIV infection and AIDS and related conditions. Abstracts are selected on the basis of their medical and scientific significance, timeliness, quality of data and methodology, adherence to specific format requirements, and other criteria described herein.

To view all updates and requirements to the abstract submission process, visit the CROI website.

Funding | HIV/Hep C in the Context of Local U.S. Opioid Epidemics (Registration Due 9/12)

Public Policy Awards: Addressing HIV and/or Hepatitis C in the Context of Local U.S. Opioid Epidemics

Funding and Performance Period
Up to $70,000 (including indirect costs at a maximum rate of 20%) for projects to be completed by November 30, 2018.

Registration Deadline: September 12, 2017, 3:00 PM EDT (You must register in order to submit.)
Concept Paper Submission Deadline: September 14, 2017, 3:00 PM EDT

Click here for complete information about the RFP and how to apply.

Purpose and Priority Areas of Interest
This RFP seeks to fund organizations working at the state or local level on efforts to address HIV and/or hepatitis C in the context of the opioid epidemic. Successful applications will incorporate the use of amfAR’s Opioid & Health Indicators Database into proposed projects.

Areas of interest are (in order of priority):

  • Identifying and addressing gaps in health care delivery for individuals diagnosed with HIV and/or hepatitis C in the context of a local opioid epidemic
  • Identifying and working to amend policies that exacerbate risk for HIV in the context of a local opioid epidemic
  • Identifying and address gaps in the availability of harm reduction and other prevention services in areas at high epidemiological risk for an HIV or hepatitis C outbreak
  • Increase awareness of amfAR’s Opioid & Health Indicators Database among local health officials, advocates, and policy makers (see description below)

amfAR’s Opioid & Health Indicators Database is a free web platform designed to support communities, lawmakers, and advocates in making informed decisions about the opioid epidemic and its impact on HIV and hepatitis C. The database is a window into the opioid epidemic unfolding in every American’s backyard. It provides local to national statistics using reliable data sources on new HIV and hepatitis C infections, opioid use and overdose death rates, and the availability of services such as drug treatment programs and syringe exchange services. In addition, users can examine data at the state or county level to see the differential impact of the opioid epidemic by state or within states.    

Topics of interest relevant to this RFP include:

  • Naloxone availability (e.g., third party prescriptions) and availability to law enforcement and other government employees, as well as affordability
  • Syringe services program availability, determination of need process, or legal barriers including paraphernalia laws
  • Medication-Assisted Treatment availability (Buprenorphine, Methadone, Naltrexone) and treatment program capacity
  • Roadblocks to Medication-Assisted Treatment (e.g., prior authorizations, lifetime limits, patient caps)
  • Health insurance coverage for people with opioid use disorder
  • Reducing perinatal hepatitis C infection
  • Prescriber education about opioid abuse (clinics, private physicians, medical or dentistry schools, etc.)
  • Law enforcement education about opioid abuse and people with opioid use disorder

**Project directors must register to receive instructions and portal user name and password for submission of a Concept Paper in response to this RFP.  See the RFP for details.  Log-ins are not transferable. 

Paid Internship | Viral Hepatitis Program Assistant (CUNY School of Public Health)

Job Title: Program Assistant

Viral Hepatitis Program at NYC Health Department

*Applicant must be a student at CUNY School of Public Health

Program Description:

The NYC Health Department, Bureau of Communicable Disease, Viral Hepatitis Program (VHP) works to reduce morbidity and mortality associated with Hepatitis B and C in NYC. The Capacity Building unit within VHP administers multiple direct service programs through contracts with syringe exchange programs, community organizations, hospitals, and health centers.

The Hep C Peer Navigation Program and the Check Hep C Patient Navigation Program provide hepatitis C outreach, prevention, navigation through complete diagnostic testing and treatment, retention in care and reinfection prevention services.

Intern Responsibilities, assist with:

  • Meeting planning, meeting notes, and follow up items.
  • Site visits with staff at contracted organizations throughout NYC
  • Developing strategies to assist programs in recruitment and linkage to care
  • Training and technical assistance
  • Protocol, form and documentation updates
  • Report writing
  • Complete other tasks as assigned

Preferred Skills:

  1. Proficiency in Microsoft Word, Excel, Access, PowerPoint
  2. Applicant must be interested in public health program implementation and capacity building.
  3. Comfort with public speaking: providing training, presentations at community meetings and conferences
  4. Highly organized with attention to detail
  5. Excellent written, oral and interpersonal skills

Hours per week: 19

Start date: As soon as possible

If interested, send cover letter and resume to Diana at

Governor Cuomo Expands NYS’s Efforts Against Opioid Epidemic

Governor Cuomo Introduces Aggressive Expansion of State’s Efforts to Fight the Opioid Epidemic

On August 7, New York became the first state in the nation to provide no-cost or lower-cost naloxone at pharmacies across New York.

  • On August, 7th Governor Cuomo announced a first-in-the-nation program to provide no-cost or lower-cost naloxone at pharmacies across New York.
  • Beginning August 9, 2017, individuals with prescription health insurance coverage, including Medicaid and Medicare, will receive up to $40 in co-payment assistance, resulting in reduced cost or no cost for this lifesaving medicine.
  • Uninsured individuals and individuals without prescription coverage will still be able to receive naloxone at no cost through New York’s network of registered opioid overdose prevention programs.
  • As of August 9, 2017, New Yorkers can find co-payment information at pharmacy counters across the state and at:

o – Individuals should provide this information to the pharmacist when asking for naloxone in order to receive it with no or lower out-of-pocket expense. The Naloxone Co-payment Assistance Program is funded by New York State’s Opioid Overdose Prevention Program.

o   Additionally, through New York’s network of registered opioid overdose prevention programs, uninsured individuals and individuals without prescription coverage will be able to receive naloxone at no cost. A full list of these programs is available here.

Free Recovery Coach Training (Applications due 9/6/17)

Please submit application with the requested recommendation by Wednesday, 9/6 by 5 PM. All applicants will be notified by Friday, 9/8.

The NYC Health Department is accepting applications for the next free Connecticut Community for Addiction Recovery (CCAR) Recovery Coach Academy to be held on Monday, 9/18 through Friday, 9/22  (5 days).

Participants of the training will receive the Recovery Coach training at no cost, as well as breakfast, lunch and Metrocards on training days. Participants must attend all 5 days of the training to receive their certification of completion. Participants will also receive 30 CASAC training hours.

About the Recovery Coach Opportunity

  • A Recovery Coach can support someone in recovery or working toward recovery from addiction. Recovery Coaching is an ongoing relationship that helps those who are in or considering recovery to achieve positive change in their lives.
  • Recovery coaches help people start and maintain recovery from substance use disorder or addiction by helping to develop a recovery plan, removing barriers and obstacles to recovery, and helping people find services and support (like harm reduction, detox, or support groups).
  • Being Recovery Coach certified makes you eligible for jobs with stable funding, such as jobs funded by state justice systems, or federal grants.
  • You can read more about being a Recovery Coach in NYS here.


To apply, fill out then sign, date and return the application to or fax to 347-396-8975, Attention: Lila Boyer. Call 347-396-4992 to verify receipt. Please submit applications with the requested recommendation by Wednesday, 9/6 by 5 PM. All applicants will be notified by Friday, 9/8.

*If you are a peer, please fill out the regular training application. If you are staff who will be directly supervising peers, please fill out the Supervisor application.

Call for Abstracts | International Conference on Viral Hepatitis (Deadline 8/18/17)

The abstract submission deadline has been extended to 5:00 pm ET, August 18, 2017Click here to submit your abstract(s) online.

The 2017 International Conference on Viral Hepatitis (ICVH 2017) will take place October 9-10, 2017, at the Gleacher Center in Chicago. ICVH 2017 is sponsored by the International Association of Providers of AIDS Care (IAPAC), in partnership with the Alliance to Eliminate HIV/HCV Coinfection (AEH2C).

The conference Co-Chairs are Nancy Reau, MD (Rush University Medical Center, Chicago, IL, USA) and Vicente Soriano, MD, PhD (Hospital Carlos III, Madrid, Spain).

The conference’s target audience includes liver specialists (hepatologists and gastroenterologists) and infectious disease (ID) and non-ID-specialized physicians, nurses, and pharmacists.

Online registration is now open. Early Registration is $100 for IAPAC members and $125 for non-IAPAC members. The Early Registration deadline has been extended to August 18, 2017.

ICVH 2017 welcomes abstract submissions in a wide variety of domains, including:

  • HBV or HCV Elimination
  • HBV or HCV Clinical Management
  • HBV or HCV Drug Resistance
  • HBV or HCV Treatment Challenges
  • Investigational Agents/New Strategies (HBV or HCV)
  • Screening and Testing
  • Coinfection with HIV
  • Investigational Agents/New Strategies (HBV or HCV)
  • Complications of Liver Disease and/or its Treatment

The abstract submission deadline has been extended to 5:00 pm ET, August 18, 2017. Submitted abstracts will be considered for oral or poster presentation. Submitted abstracts should report information not previously published, or intended to be published, prior to October 9, 2017. A notice of acceptance or rejection will be sent via e-mail no later than September 15, 2017.

Click here to submit your abstract(s) online.

Call for Abstracts | U.S. Conference on African Immigrant Health (Deadline 8/15/17)

Conference Info: October 5th – 8th, Washington DC. Read more about the conference here, and register here.

Deadline for abstract submission: August 15th

Abstracts are invited for poster and oral presentations related to all health issues affecting the African Diaspora, these can be advanced through research and advocacy and engagement within the context of their culture, integration processes and challenges.

Researchers, clinicians, graduate students, legislators, academics, policy makers, community service organizations and community members are especially encouraged to submit a 200-250 word abstract of research or applied projects (programs, training, policies, etc.), and participate in the conference.

The abstract should fit within the overall conference theme, Advancing the health of African Immigrants through Research, Advocacy and Community Engagement, and reflected through one of the following sub-themes or tracks:

Conference Tracks

  • Behavioral and Mental Health
  • Infectious Diseases
  • Chronic Diseases
  • Religion, Culture and Health
  • Research and Practice in African Immigrant Communities
  • Immigration, Integration and Health
  • Education, Training and Workforce Development

Student Poster Session

  • ATTENTION: Undergraduate and Graduate Students:  In addition to regular research workshops sessions, this years USCAIH conference solicits a special call for abstracts for students poster presentations on a research or applied projects (programs, training, policies, etc.) you are working on or have completed.
  • As with the regular workshop sessions, the abstract should fit within the overall conference theme, Advancing the health of African Immigrants through Research, Advocacy and Community Engagement, as explored through one or more of the 7 sub-tracks.
  • Please note: A Poster is a graphic presentation of your research. The student author(s) should illustrate their research findings or project content by using a reduced amount of text with a focus on displaying results via graphs, charts, photos, and diagrams.
  • This student poster session will take place during a designated day and time at the annual meeting.  Student authors must be prepared to be at the poster during the assigned time period to facilitate discussions and answer questions with attendees who will be circulating among the poster boards. It is helpful to present a brief over of your research/program/project/practice. This will help answer obvious questions and then allow more time for in-depth discussions.
  • Abstracts for student poster sessions should be SUBMITTED HERE 

Submission Guidelines

Please read the following guidelines carefully before submitting your abstract

  • All authors are requested to choose a topic area for their abstract during the submission process
  • All abstracts must have a title, name(s) or author(s) and institutional/organization or community affiliation.
  • Abstracts based on primary research must contain background, objective(s), methods, results, and discussion/conclusion. Those based on applied research must contain introduction, the problem or issue, activities or strategies, and outcomes/lessons learned.
  • Student presenters must either be currently in school or had completed the work while they were a student studying. The student submitting the abstract must be the first author. Faculty advisor(s) must be noted on the abstract.
  • Up to three authors may be identified as co-presenters
  • The presenting author may not present on more than two (2) accepted papers
  • You do not have to be registered for the conference in order to submit an abstract. If your abstract is accepted, you   will be required to show proof of registration to confirm your attendance as presenter. You may register here.



  • Abstract Submission Deadline:      August 15, 2017
  • Abstract Notification Date:           September 1, 2017
  • Preliminary Program Available:     September 20, 2017

Funding | African Humanities Fellowships – ACLS (Deadline 11/2/17)

Deadline: November 2, 2017

The American Council of Learned Societies, a private nonprofit federation of seventy-three national scholarly organizations, is the preeminent representative of American scholarship in the humanities and related social sciences.
The mission of the program is to encourage and enable the production of new knowledge and new directions for research, strengthen the capacity of early-career researchers and faculty at African universities, and build the field of humanities by establishing networks for scholarly communication across Africa and with Africanists worldwide.

Fellowship stipends allow recipients to take an academic year free from teaching and other duties for completion of his/her PhD dissertation, the revision of a dissertation for publication, or to conduct a first major research project after the PhD. Fellows are also eligible for additional benefits such as residential stays for writing, manuscript development workshops, and publication support.
Each fellow may request a residential stay at an African institute for advanced study, but residencies must be taken at an institute outside the home country. Currently, AHP Fellows may take residencies at six institutes, from South Africa to Senegal, Ghana to Tanzania.
Fellows are invited to submit their manuscripts to the AHP Publications series, a collaboration with UNISA Press in Pretoria, South Africa. In addition, fellows may apply to attend a manuscript-development workshop to discuss their manuscripts with AHP mentors and other fellows in an intensive, weeklong retreat. Many authors use these discussions to guide their final revisions before submitting manuscripts for publication.

AHP also partners with the African Studies Association every year to bring select AHP Fellows to the ASA annual meeting.
For further details on eligibility, submission of applications, and selection criteria, see the ACLS website.

Click here to view the complete RFP.

Hep C Advocates – Take action against the Hep C epidemic!

In response to the recent National Academies of Sciences, Engineering, and Medicine’s (NASEM) release of A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report, and following World Hepatitis Day (July 28), NASTAD has issued a Call to Action for an urgent response to the hepatitis C epidemic. The Call to Action proposes the following set of recommendations to prevent new infections; reduce deaths and adverse health outcomes; address disparities; coordinate action among federal, state, and local agencies and health systems; and ultimately reduce health care costs.

Action Steps:

  1. Focus on Prevention, Care, and Treatment for Priority Populations: The opioid epidemic is pervasive in rural, urban, and suburban America. HCV prevention, care, and treatment must be part of a comprehensive strategy to address the epidemic. People of color, Native Americans, homeless individuals, incarcerated populations, and people co-infected with HIV and HCV are disproportionately impacted by HCV and need to be engaged in efforts to end this epidemic.
  2. Address the Opioid Epidemic and Drug User Health: The most cost effective strategy to prevent new HCV infections is to ensure a robust drug user health service infrastructure, with harm reduction strategies at the center, is in place in states and localities, and supported by federal resources.
  3. Screening, Diagnosis, and Link to Care: Effort must be made to reach those most vulnerable for HCV by implementing screening and related services within the community, which often means outside of the clinical care setting. Improving the hepatitis C surveillance infrastructure, including making more resources available to support states and cities, is also critical.
  4. Treatment and Follow Up: In response to the high initial cost of direct-acting antiviral HCV medications, many private and public health insurance payers responded by restricting access to these relatively new medications to those with the most advanced disease and who were not actively using drugs. With elimination as the goal, treatment must be accessible and affordable to everyone, and especially those living with HCV who have been subject to discriminatory, arbitrary sobriety requirements.

NASTAD’s vision is that new HCV infections in the United States are rare, and when they do occur, every person, regardless of substance use status, age, gender, race/ethnicity, sexual orientation, gender identity, disability, socio-economic status, incarceration status or geographic location, will have access to quality, affordable health care including comprehensive screening, care, and treatment leading to cure, without stigma and discrimination.

NASTAD believes that eliminating HCV should be a top public health priority. Unless we act boldly and urgently, we will continue to lose ground against the hepatitis C epidemic. We are hopeful that stakeholders at the national, state, and local levels will join our efforts to make the elimination of HCV in the U.S. a reality.

For more information on NASTAD’s Call to Action, or hepatitis program and policy activities, please contact Chris Taylor, Senior Director, Hepatitis.

Please distribute to your networks. Thank you for your commitment to ending the hepatitis C epidemic!

FDA Advisory Panel Votes in Support of 2-Dose Hep B Vaccine

July 28th, 2017:

The US Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee voted 12-1 in favor of recommending the Dynavax 2-dose Hep B vaccine, Heplisav-B, for licensing in adults aged 18 years and older.

While trials have shown Heplisav-B to be effective, its safety profile is still under evaluation.

Hepsilav-B has been praised for its shorter schedule: instead of three doses given over 6 months, as is the practice with current rival products, Hepsilav-B is given in two doses over 1 month. This shorter schedule is important because it increases the likelihood that more individuals will receive the full dose schedule and therefore the full protection offered by the vaccine.

While advisory panel recommendation does not assure the FDA will approve the vaccine, it typically does result in approval. The FDA is expected to make its decision regarding the approval of Heplisav-B this August.

Click to read more on the clinical trials of Hepsilav-B, the potential impact of Hepsilav-B approval, and Dynavax’s press release following the vote.

Press Release | World Hepatitis Day 2017 (NYC Health Dept)

Press release on NYC Health Department website:

News Coverage:

Full text:

July 28, 2017 – In recognition of World Hepatitis Day, the Health Department today released new preliminary data on hepatitis B and C in New York City. From 2015 to 2016, there was a 9.4 percent increase in newly reported hepatitis B cases; the rise is likely due to screenings targeted at New Yorkers who were born in countries with a high prevalence of the virus. Newly reported chronic hepatitis C cases, meanwhile, declined slightly, from 4,171 in 2015 to 3,781 in 2016. The Health Department has a number of programs devoted to the prevention and treatment of hepatitis. The Project INSPIRE hepatitis C comprehensive care coordination program closed enrollment in February 2017, and was found to improve health care and lower costs for the 2,775 patients served. In January, the agency also started a program to connect pregnant women with hepatitis B to affordable care after the birth of their child.

The repeal of the Affordable Care Act would have severe and negative impacts on the communities benefiting from these essential programs. Proposals under consideration include deep cuts to Medicaid funding and the removal of vital insurance protections, including health insurance for people with pre-existing conditions and coverage for essential health benefits.

“Although we have made progress in expanding screenings and treatment for hepatitis B and C, we will not be satisfied until we see an end to hepatitis in New York City,” said Health Commissioner Dr. Mary T. Bassett. “We will continue to work with our community partners to expand access to treatment and reach communities that have been disproportionately affected by this disease. It is now easier than ever to get tested, and all New Yorkers should know their status.”

Preliminary data highlights:

  • In 2016, 8,439 people were newly reported with chronic hepatitis B, an increase from 7,719 in 2015.
  • The highest rate of chronic hepatitis B continues to be seen in Sunset Park, Brooklyn at 755.7 per 100,000 people. Other neighborhoods with high rates of chronic hepatitis B were Borough Park and Bensonhurst/Bay Ridge (Brooklyn), Flushing and West Queens (Queens), Greenwich Village/SoHo and Union Square/Lower East Side (Manhattan).
  • 43 percent of those diagnosed with chronic hepatitis C were born between 1945 and 1965.
  • 14.8 percent of patients diagnosed with chronic hepatitis C were under 30 years of age, slightly higher than in 2015 (12.4 percent).
  • Neighborhoods with the highest hepatitis C rates were Chelsea-Clinton, East and Central Harlem (Manhattan), Coney Island (Brooklyn), and Hunts Point-Mott Haven (Bronx), similar to 2015.

“In this era of highly effective, short-course and well-tolerated therapy for hepatitis C, patients should be identified by complete diagnostic testing,” said Dr. Demetre Daskalakis, Deputy Commissioner for the Division of Disease Control. “The best way to test for hepatitis C is to conduct the antibody with reflex to RNA to confirm infection in one step. Positive individuals should be offered curative therapy to reduce their risk of long term liver complications.”

“We want all New Yorkers, especially those born in countries with high rates of hepatitis B, to get tested and receive appropriate medical evaluation, and ongoing monitoring and treatment for hepatitis B to prevent serious liver disease and cancer. In addition, testing New Yorkers with current or past risk factors for hepatitis C, including baby boomers and people who use drugs, is critical,” said Dr. Ann Winters, Medical Director of the Health Department’s Viral Hepatitis Program.

“I applaud the Department of Health for working to raise awareness of hepatitis in New York City and I am proud to be leading the effort on the federal level, “ said U.S. Rep. Grace Meng (D-Queens), Co-Chair of the Congressional Hepatitis Caucus. “It is critical that we continue to educate the public about hepatitis and do all we can to expand screening and treatment for the virus. I am proud to have introduced a resolution in Congress expressing support for World Hepatitis Day, and to have requested in appropriations legislation that the National Institute of Health intensify its current effort to find a cure. We will not rest until we end hepatitis once and for all.”

“New York City is a leader in hepatitis screening and care,” said Assembly Health Committee Chair Richard N. Gottfried.  “We must continue expanding outreach, particularly in underserved communities, so that all New Yorkers know their status and can access treatment without financial barriers.”

“The City offers vital services geared toward preventing and treating hepatitis B and C in communities across New York City. Potential cuts to the Affordable Care Act could trickle down and have considerable harm to the people benefiting from these program and their ability to pay for essential health services,” said Council Member Jumaane D. Williams.

The City has expanded services for hepatitis screening and treatment in the last two years, including:

Project INSPIRE is a comprehensive hepatitis C care coordination program at Mount Sinai in Upper Manhattan and Montefiore Medical Centers in the Bronx. At the close of enrollment in February 2017, 2,775 people chronically infected with hepatitis C were enrolled to receive support through medical evaluation, treatment to cure infection and management of co-morbid conditions. The project makes a case for health insurance to cover care coordination services to reduce high cost medical care and hospitalization due to unmanaged chronic hepatitis C.

The New York City Council “Viral Hepatitis Initiative” was first funded in 2014, which allowed the Health Department to develop a citywide hepatitis B and hepatitis C patient and peer navigation program, as well as a clinical provider training program. In FY2018, this initiative will provide over $2 million to community health organizations serving high-risk populations. As of last month, this program has trained and supported 31 community health organizations to:

  • Enroll and educate 8,128 residents at risk for or living with hepatitis B or C.
  • Link 3,126 patients to hepatitis medical care.
  • Assist 1,794 patients in completing a comprehensive medical evaluation necessary for treatment.
  • Train over 800 clinical providers in hepatitis screening, management and treatment.

The Hep B Moms Linkage to Care program launched in January to link pregnant women with hepatitis B to affordable hepatitis B care after the birth of their child. The majority of patients are foreign born, have limited English proficiency, and many only have access to health insurance during pregnancy. Through this project, bilingual health care access specialists at the Health Department provide intensive telephone-based linkage to care services. The program will serve at least 400 patients over two years.

Project SUCCEED (Scaling up Co-Infection Care & Eliminating Ethnic Disparities) launched last September when the Health Department was awarded a three year Health and Human Resources (HRSA) Ryan White Special Projects of National Significance (SPNS) grant. The goal of Project SUCCEED is to increase hepatitis C screening, linkage to care, treatment and cure rates among persons living with HIV in New York City, the majority of whom are people of color. As of December 2016, over 11,000 persons living with diagnosed HIV have screened hepatitis C antibody positive, and nearly 4,000 have confirmed current hepatitis C infection. Project SUCCEED will use Health Department surveillance data to target interventions which include training and technical assistance for HIV clinical and non-clinical providers, as well as direct to patient outreach and linkage to hepatitis care services. The project includes a strong evaluation component in the hopes that many of the elements of the intervention will be able to be used in other jurisdictions.

Many people living with hepatitis B or C are unaware of their infection and not receiving medical care, yet are at risk for developing liver cirrhosis and cancer. Chronic hepatitis C infection can be treated and cured. Hepatitis B can be prevented through vaccination, and chronic hepatitis B infection can be treated to slow the progression of disease.

The Health Department urges all New Yorkers to:

  • Learn your risk for hepatitis B and C. Visit or text the word “LIVER” to 877877.
  • Get tested if you are at risk. Ask your doctor for the test, or find a hepatitis B or C testing and treatment site near you using the Health Department’s NYC Health Map.
  • Protect yourself and your loved ones from hepatitis B. Ask your doctor for the hepatitis B vaccine.
  • If you are living with hepatitis B and/or C, learn more about how to stay healthy. Visit or download the NYC Liver Health app.


Job | Syringe Access Policy Organizer @ AIDS United

To apply, a cover letter with salary requirements and resume should be submitted to with “Syringe Access Policy Organizer” in the subject line.  Incomplete applications WILL NOT BE CONSIDERED.

AIDS United seeks to hire a Syringe Access Policy Organizer to provide policy, advocacy, and regulatory capacity in support of state and federal efforts to increase the availability of syringe access programs throughout the United States.  This position will be responsible for organizing diverse parts of AIDS United’s Syringe Access work into a coherent and efficient whole. The position will engage AU’s unique national and local resources to highlight syringe access as a key and strong response to the intertwined HIV, hepatitis C, drug overdose, and opioid addiction epidemics.   The position will work to ensure successful regulatory engagement and implementation of syringe access at the state and federal level.  The position will engage in non-partisan analysis/research, and supporting state and federal coalitions working on these goals. Primary responsibilities will be to work with AIDS United Public Policy Committee Members, Syringe Access Fund (SAF) coalition grantees, Coalition for Syringe Access members and other collaborating organizations on increasing syringe access.  The position will additionally assist the SAF in finding potential funding targets to increase funding commitments to the SAF.  Primary duties include federal and state research, education and advocacy, administrative and regulatory review and activities and fundraising support.

Qualified candidates must have five years of relevant experience or a Bachelor’s degree with three years of experience.  Comparable work or life experience relevant to the responsibilities of the position may include community organizing, volunteering, self-advocacy or service delivery on the topics of HIV, hepatitis C, drug use, harm reduction and syringe access.

Position requires a highly organized individual with a proven ability to work within a coalition.  Individual must be an efficient project organizer, capable of multitasking, and have the ability to take initiative and be self-directed in completing daily tasks. Candidates must maintain a high level of professionalism, maintain up to date knowledge on harm reduction and syringe access and handle assignments with a high degree of accuracy and confidentiality.  Position requires strong research and writing skills and communications abilities.  Must be able to work in a fast-paced environment and work independently as well as a member of a team.  A successful candidate must be proficient in MS Word, MS Excel, and PowerPoint.  Proficiency in social media and other communications platforms is desirable.

Responsibilities include:

  • Work within coalition on issues affecting syringe access, HIV and viral hepatitis prevention issues;
  • Review and provide comments on regulations related to syringe access;
  • Provide information, appropriate materials and staffing, non-partisan analysis and research work for AU member and grantee organizations, particularly in states in which there is potential movement on syringe access;
  • Produce written content, including assisting in writing, editing AIDS United’s Policy Update, drafting letters, policy-related documents, fact sheets and other written communication materials as needed; and
  • Work with Policy and Program Directors to identify potential supporters for the Syringe Access Fund.

The position is expected to be funded through September 1, 2018.  Work is generally performed within the office environment and includes significant contact with partners and the public.  Position will likely require 14-16 days of travel per year.

To apply, a cover letter with salary requirements and resume should be submitted to with “Syringe Access Policy Organizer” in the subject line.  Incomplete applications WILL NOT BE CONSIDERED.  Due to the high volume of applicants only those selected for an interview will be contacted.

AIDS United is an Equal Opportunity Employer. All qualified applicants will be considered for employment without unlawful discrimination based on race, color, creed, national origin, sex, age, disability, marital status, sexual orientation, military service/veteran status, citizenship status, genetic information, prior record of arrest or conviction, citizenship status, current employment status, or caregiver statusgenetic information, or any other protected status under federal, state or local law.

We encourage applications from candidates of color and individuals living with HIV or histories of injectable-drug use.  AmeriCorps, Peace Corps, and other national service alumni are also encouraged to apply. No phone calls please.

Click here to view this posting on the AIDS United website.

7-12-17 Harlem Hep C Task Force Meeting Highlights

Read full meeting highlights here.

Statewide Hep C Elimination Plan
Angie Woody MPH, Policy Analyst, VOCAL-NY –

5th Annual African American Hepatitis C Action Day – July 25, 2017
Melissa Baker, Vice President, NBLCA –

Project INSPIRE Accomplishments and Next Steps
Bridgette Buquez, Care Coordinator, Mount Sinai –
Natasha Toussaint, Care Coordinator, Mount Sinai –

NYC Hep C Policy and Advocacy Updates
Nirah Johnson LCSW, NYC Health Dept –

Hep Free NYC Committee Updates
Daniel Calder, NYC Health Dept –

Job | Research Assistant @ NVHR

Job Description

NVHR (National Viral Hepatitis Roundtable) is seeking a Research Assistant for the “Hepatitis C – It’s About More Than Liver Disease” project. The Research Assistant will gather the latest medical evidence on all of the extrahepatic manifestations of hepatitis C in preparation for developing a fact sheet. The fact sheet will outline how hepatitis C intersects with other disease states and how curing patients of their hepatitis C may help improve health conditions beyond liver function. Throughout the research and development of materials phase, NVHR will work to engage new partners.


The Research Assistant (10-15 hours/week) will report to the Program Director, and will work with the Program Director and Program Coordinator to develop and complete the “Hepatitis C – It’s About More Than Liver Disease” project. Project tasks will include the following activities:

  • Conduct a literature review on the extrahepatic manifestations of hepatitis C.
  • Work with the Program Director to write summary reports on what was found in the literature.
  • Assist NVHR’s Program team with development of the “Hepatitis C – It’s About More Than Liver Disease” fact sheet.
  • Assist NVHR’s Program team with development of a webinar for the “Hepatitis C – It’s About More Than Liver Disease” project.
  • Research new potential partner organizations that may be interested in receiving the fact sheet and partnering with NVHR in awareness and advocacy efforts (e.g., organizations focused on cardiovascular, renal, metabolic and central nervous system diseases).
  • Other duties as requested.


Required Qualifications

  • 2nd year Masters level or PhD-level student in public health, social work, health services, or related field; or two years of relevant experience
  • Have a computer with reliable internet access.
  • Available a minimum of 10 hours per week.
  • Excellent writing, editing, and interpersonal communication skills.
  • Experience with conducting literature reviews.
  • Good decision-making and organizational skills, as well as close attention to detail.
  • Self-directed/self-starter with ability to manage multiple projects simultaneously.
  • Personality suited for working in a small organization where teamwork and resourcefulness are highly valued.
  • Ability to adhere to project milestone deadlines.
  • Familiarity with and comfort using online tools such as Dropbox and Google Drive


Preferred Qualifications

  • 1 year of experience conducting literature reviews.
  • Personal experience with challenges affecting the viral hepatitis community, including experience living with hepatitis B or hepatitis C.
  • Experience working with a remote team.


How to apply

Qualified candidates should send resume, cover letter, and 2-3 page writing sample to Tina Broder, Program Director, Subject line should read “Research Assistant” only.

Community Initiatives and NVHR value a diverse, respectful, and collaborative work environment. We establish and maintain trustful relationships with all staff, contractors, funders, partners, and communities. The above statements are intended to describe the work being performed by people assigned to this job. They are not intended to be an exhaustive list of all responsibilities, duties, and skills required of the personnel so classified. Community Initiatives/NVHR is an equal opportunity employer and gives consideration for employment to qualified applicants without regard to age, race, color, religion, creed, sex, sexual orientation, gender identity or expression, national origin, marital status, disability or protected veteran status, or any other status or characteristic protected by federal, state, or local law.

Click here to download the pdf of this announcement.

Job | Manager, Drug User Health @ NASTAD

Apply online.
Company Description

NASTAD is a non-profit national association that represents public health officials who administer HIV and hepatitis health care, prevention, education, and supportive service programs funded by state and federal governments in all 50 U.S. states, the District of Columbia, Puerto Rico, the U.S. Virgin Islands, and the U.S. Pacific Islands. NASTAD also supports partner governments in Africa, the Central America region, and the Caribbean region.

NASTAD’s vision is a world free of HIV and viral hepatitis.

Job Description

The Manager, Drug User Health plays an essential role in supporting NASTAD’s technical assistance, capacity building, and advocacy work as it relates to mounting an effective response among health departments to promote the health of people who inject drugs (PWID) including the prevention and care and treatment of HIV, hepatitis C (HCV) and overdose. This position works closely with the Hepatitis, Prevention, Health Care Access and Health Systems Integration teams to support programmatic activities, with a focus on deliverables related to improving the health outcomes for people who use drugs.

Essential Duties
  • Participate in strategic discussions and recommend innovative and/or science/research-based steps in addressing the HIV, hepatitis, and overdose epidemics among people who inject drugs (PWID)
  • Assess state/local health department program development needs to strengthen drug user health programming for PWID
  • Provide tailored and impactful capacity building assistance, technical assistance and training to key jurisdictions to strengthen drug user health programming for PWID
  • Work across NASTAD teams to identify meaningful ways to incorporate drug user health issues into current deliverables and scopes of services
  • Represent NASTAD in various meetings with federal and national partners and other stakeholders
  • Support the Policy and Legislative Affairs team as a content expert on drug user health
  • Attend and represent NASTAD at conferences and participate in relevant external meetings
  • Perform other duties as assigned
Minimum Qualifications
  • Bachelor degree or higher in public health, public policy or related fields; or any equivalent combination of training, education and experience that demonstrates the ability to perform the duties of the position
  • Minimum of 4-5 years of progressively responsible work experience related to health care programs and policies preferred
Minimum Competencies
Skills, knowledge, and abilities
  • Demonstrated technical expertise of drug user health issues, including HIV and hepatitis prevention, care and treatment, harm reduction, substance use prevention and treatment and overdose prevention
  • Analytical Thinking: The ability to tackle a problem by using a logical, systematic, sequential approach
  • Stakeholder Orientation: The ability to demonstrate concern for satisfying one’s external and/or internal stakeholders
  • Fostering Teamwork: As a team member, the ability and desire to work cooperatively with others on a team
  • Oral Communication: The ability to express oneself clearly in conversations and interactions with others
  • Written Communication: The ability to express oneself clearly in business writing.
  • Attention to Communication: The ability to ensure that information is passed on to others who should be kept informed
  • Building Collaborative Relationships: The ability to develop, maintain, and strengthen partnerships with others inside or outside the organization who can provide information, assistance, and support
  • Advanced Written Communication: The ability to use formal writing styles or advanced literary techniques and formats suited to the audience
Additional Information
Environment and Scheduling
  • Interest in working with a national HIV and hepatitis public health organization
  • Interest in working within a diverse environment
  • Willing to travel as needed


Apply online.

New! NYS Hep C Treatment Guidelines

The New York State (NYS) Department of Health (DOH) AIDS Institute (AI) has developed and released a guideline on screening, diagnosis, and treatment of chronic hepatitis C virus (HCV) infection to guide primary care providers and other practitioners in New York State in treating patients with chronic hep C.

The NYS DOH AI is publishing these guidelines at a critical time: 1) new treatments are available that can cure chronic HCV infection; 2) the burden of HCV disease is increasing in NYS [1]; and 3) primary care providers and other clinical care practitioners in NYS are playing an essential role in screening for and diagnosing chronic HCV infection and in providing state-of-the-art therapy for their patients.

Read the guideline here, and learn more about HCV trainings, care, and provider resources here.


  1. Centers for Disease Control and Prevention NCfHS. Multiple Cause of Death 1999-2015 on CDC WONDER Online Database, released December, 2016. [accessed March 21, 2017].

Comment | NYC Health Code Amendment – Hep C Reflex RNA Testing (Due 7/27/17)

The NYC Department of Health is considering a proposed amendment to the Health Code. The proposed amendment to Health code §13.03(b)(3) would require laboratories to routinely perform a confirmatory RNA hepatitis C virus (HCV) test when there is a positive HCV antibody test result.

View a summary of the amendment as a PDF

Most patients are first screened for HCV via an antibody test, which shows whether the patient has ever been infected with the virus; patients testing positive must then receive RNA confirmatory testing, often requiring the patient to return for another blood test. This multi-step testing process results in treatment delays and patients being lost to care:
in 2015 in NYC, 22% (1,638) of newly reported patients with a positive HCV antibody test never had a confirmatory RNA test.

The proposed amendment would help ensure that patients infected with HCV are aware of their infection status, and if chronic hepatitis C is confirmed, are promptly linked to medical care and treatment, and are cured.

This proposed amendment is now open for public comment! 

All comments must be made by July 27th. You can comment online, by email, mail, fax, or in-person at the public hearing.

A public hearing will be held July 27th from 2 – 4 PM at:
NYC Department of Health and Mental Hygiene
Gotham Center, 42-09 28th St., Room 3-32
Long Island City, NY 11101-4132

To comment online, you must log in or register. You can then write and submit your comment from the amendment page.

To comment by mail, mail to:
NYC Department of Health and Mental Hygiene
Gotham Center, 42-09 28th St., CN 31
Long Island City, NY 11101-4132

To comment by fax, fax to:
NYC DOHMH, 347-396-6087

6-7-2017 Staten Island Hep C Task Force Meeting Highlights

Read full meeting highlights here

Hep C Services at  Brightpoint Health Bay Street Health Center
Jonathan Zellan MD, Vice President and Regional Medical Director –

Hep C Services at Community Health Action of Staten Island
Sharon Ann Jensen BSW, Director of Testing and Benefit Services –

NYC Hep C Policy and Advocacy Update
Nirah Johnson, NYC Health Dept. –

Screening of Hep C Prevention in Youth Video
Jazmin Rivera MPH, Tackling Youth Substance Abuse –

Job | HIV/Hep C Health Care Access Specialist @ NYC Health Dept, Project SUCCEED

HIV/Hep C Health Care Access Specialist @ NYC Health Dept, Project SUCCEED

Apply Online

Job Description

The NYC Department of Health, Bureau of Communicable Disease, Viral Hepatitis Program (VHP) works to reduce morbidity and mortality associated with Hepatitis B and C in NYC.  VHP conducts surveillance, community outreach, training and organization, program development and implementation and policy activities.

Roles and Responsibilities

• Conduct telephone based patient navigation services: outreach to individuals infected with HIV/HCV, brief assessment, provision of referrals for supportive services, linkage to care, retention in care, treatment support.

• Conduct on-site and telephone or web-based trainings and technical assistance in HIV/HCV co-infection care best practices for non-clinical providers at Ryan White Care Coordination Programs, and other organizations serving HIV/HCV infected patients.

• Collaborate with Project SUCCEED leadership to develop the project plan and materials including: provider training and technical assistance intervention; patient navigation protocol and resource; and patient education and health promotion materials.

• Document activities in program tracking databases; attend all necessary trainings and meetings related to Project SUCCEED; provide ad hoc reports as requested, and provide additional administrative support as required.

Minimum Qual Requirements

  1. A baccalaureate degree from an accredited college and two years of experience in community work or community centered activities in an area related to the duties described above; or
  2. High school graduation or equivalent and six years of experience in community work or community centered activities in an area related to the duties as described above; or
  3. Education and/or experience which is equivalent to “1” or “2” above. However, all candidates must have at least one year of experience as described in “1” above.

Preferred Skills

  1. Knowledge of HIV/AIDS, hepatitis C and substance abuse education and intervention strategies.
  2. Demonstrated cultural competence with populations currently most affected by HIV and hepatitis C (People who
    use drugs, African American, Latino, and men who have sex with men).
  3. Experience with developing and delivering training.
  4. Experience with providing direct service in a medical, health, or social service setting.
  5. Proficiency in Microsoft Word, Excel, and Power Point.
  6. Excellent written, oral and interpersonal skills; ability to handle multiple and diverse assignments.

Additional Information


Please note:  If you are called for an interview you will be required to bring to your interview copies of original documentation, such as:
• A document that establishes identity for employment eligibility, such as: A Valid U.S. Passport, Permanent Resident Card/Green Card, or Driver’s license.

• Proof of Education according to the education requirements of the civil service title.

• Current Resume

• Proof of Address/NYC Residency dated within the last 60 days, such as: Recent Utility Bill (i.e. Telephone, Cable, Mobile Phone)

Additional documentation may be required to evaluate your qualification as outlined in this posting’s “Minimum Qualification Requirements” section. Examples of additional documentation may be, but not limited to: college transcript, experience verification or professional trade licenses.

If after your interview you are the selected candidate you will be contacted to schedule an on-boarding appointment.   By the time of this appointment you will be asked to produce the originals of the above documents along with your original Social Security card.


The federal government provides student loan forgiveness through its Public Service Loan Forgiveness Program (PSLF) to all qualifying public service employees. Working with the DOHMH qualifies you as a public service employee and you may be able to take advantage of this program while working full-time and meeting the program’s other requirements.

Please visit the Public Service Loan Forgiveness Program site to view the eligibility requirements:

To Apply

Apply online with a cover letter to  In the Job ID search bar, enter: job ID number # 292415.

We appreciate the interest and thank all applicants who apply, but only those candidates under consideration will be contacted.

Work Location

42-09 28th Street

Residency Requirement

New York City residency is generally required within 90 days of appointment. However, City Employees in certain titles who have worked for the City for 2 continuous years may also be eligible to reside in Nassau, Suffolk, Putnam, Westchester, Rockland, or Orange County. To determine if the residency requirement applies to you, please discuss with the agency representative at the time of interview.

Pin It on Pinterest